Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 115,511,808
  • Shares Outstanding, K 1,282,467
  • Annual Sales, $ 32,364 M
  • Annual Income, $ 3,677 M
  • EBIT $ 6,834 M
  • EBITDA $ 9,481 M
  • 60-Month Beta 0.84
  • Price/Sales 3.54
  • Price/Cash Flow 12.39
  • Price/Book 2.38

Options Overview Details

View History
  • Implied Volatility 24.43% ( +1.61%)
  • Historical Volatility 14.67%
  • IV Percentile 90%
  • IV Rank 72.51%
  • IV High 29.47% on 08/06/24
  • IV Low 11.12% on 12/04/23
  • Put/Call Vol Ratio 0.22
  • Today's Volume 14,790
  • Volume Avg (30-Day) 9,624
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 186,851
  • Open Int (30-Day) 194,072

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/24
See More
  • Average Estimate 1.24
  • Number of Estimates 13
  • High Estimate 1.26
  • Low Estimate 1.20
  • Prior Year 1.25
  • Growth Rate Est. (year over year) -0.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.88 +2.80%
on 10/07/24
92.68 -3.64%
on 10/24/24
+1.05 (+1.19%)
since 10/04/24
3-Month
79.92 +11.76%
on 08/06/24
92.68 -3.64%
on 10/24/24
+7.80 (+9.57%)
since 08/02/24
52-Week
69.32 +28.84%
on 11/10/23
92.68 -3.64%
on 10/24/24
+16.75 (+23.08%)
since 11/03/23

Most Recent Stories

More News
2 Dividend Stocks to Buy for a Lifetime of Passive Income

These are the kinds of stocks that can allow investors to sleep easy at night.

MRK : 101.87 (-0.01%)
SMMT : 19.96 (+5.11%)
MDT : 89.31 (-0.84%)
MRNA : 53.54 (-2.00%)
ISRG : 507.42 (+0.21%)
Medtronic's Q2 2025 Earnings: What to Expect

Medtronic will release its second-quarter earnings next month, and analysts anticipate a slight profit dip.

XLV : 146.77 (-0.66%)
$SPX : 5,712.69 (-0.28%)
MDT : 89.31 (-0.84%)
1 Outstanding AI Growth Stock to Grab Now

AI could soon transform the medical technology industry, and this market leader may continue to dominate.

$SPX : 5,712.69 (-0.28%)
JNJ : 158.24 (-1.18%)
MDT : 89.31 (-0.84%)
ISRG : 507.42 (+0.21%)
Should ISRG Stock Be Part of Your Portfolio Ahead of Q3 Earnings?

Intuitive Surgical, Inc. ISRG is set to report third-quarter 2024 earnings on Oct. 17. The Zacks Consensus Estimate for sales and earnings is pegged at $2.02 billion and $1.65 per share, respectively....

TMO : 555.47 (-0.44%)
MDT : 89.31 (-0.84%)
ISRG : 507.42 (+0.21%)
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions,...

ZBH : 108.41 (+1.06%)
SNN : 25.28 (+0.16%)
SYK : 366.90 (-0.07%)
MDT : 89.31 (-0.84%)
Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon

Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy?

SYK : 366.90 (-0.07%)
MDT : 89.31 (-0.84%)
ISRG : 507.42 (+0.21%)
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?

Following a slump, shares of Medtronic MDT seem to have started to recuperate, possibly banking on a gradually improving investment and research scenario, thanks to the recent monetary policy easing. Closing...

ABT : 117.65 (-0.80%)
BSX : 84.72 (+1.32%)
BDX : 234.33 (-0.39%)
MDT : 89.31 (-0.84%)
Intuitive Surgical Stock Declines 0.7% in a Month: Is It Losing Steam?

Shares of Intuitive Surgical ISRG have lost 0.7% in the past month compared with the Zacks Medical - Instruments industry’s decline of 3.4% and the broader Zacks Medical sector’s fall of 4.6%. The...

JNJ : 158.24 (-1.18%)
MDT : 89.31 (-0.84%)
ISRG : 507.42 (+0.21%)
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life

/CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global...

MDT : 89.31 (-0.84%)
New clinical data demonstrate excellent lesion durability with PulseSelectâ„¢ Pulsed Field Ablation System in real-world setting as approvals and adoption expand globally

/CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the presentation of clinical study results demonstrating a high...

MDT : 89.31 (-0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience...

See More

Key Turning Points

3rd Resistance Point 91.45
2nd Resistance Point 90.98
1st Resistance Point 90.15
Last Price 89.31
1st Support Level 88.84
2nd Support Level 88.38
3rd Support Level 87.54

See More

52-Week High 92.68
Last Price 89.31
Fibonacci 61.8% 83.76
Fibonacci 50% 81.00
Fibonacci 38.2% 78.24
52-Week Low 69.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar